Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide
Open Access
- 31 May 1991
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 41 (2) , 113-116
- https://doi.org/10.1016/0090-8258(91)90268-a
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetateGynecologic Oncology, 1989
- Cisplatin- based chemotherapy of epithelial ovarian cancerJournal of Surgical Oncology, 1989
- Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaGynecologic Oncology, 1987
- Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: A Southwest Oncology Group studyGynecologic Oncology, 1987
- Adriamycin and cis-diamminedichloroplatinum in the treatment of metastatic endometrial adenocarcinomaGynecologic Oncology, 1984
- Combination chemotherapy for advanced endometrial cancer. An evaluation of three regimensCancer, 1982
- Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5-fluorouracil, and megestrol acetateAmerican Journal of Obstetrics and Gynecology, 1981
- Doxorubicin-cyclophosphamide: Effective chemotherapy for advanced endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1977
- Progestational Agents in the Treatment of Carcinoma of the EndometriumNew England Journal of Medicine, 1961